Treatment of pulmonary arterial hypertension in pregnancy

American Journal of Health-System Pharmacy

Volumn 64, Issue 18, 2007, Pages 1922-1926

  Huang, Sheilyn ^a   DeSantis, Evelyn R Hermes ^b,c  

^a Scientific Connexions   (United States)

^b ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Anticoagulants; Calcium antagonists; Dosage; Epoprostenol; Heparins; Hypertension; Iloprost; Nitric oxide; Pregnancy; Sildenafil; Site of action; Toxicity; Vasodilating agents; Warfarin

Indexed keywords

ARGININE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; NIFEDIPINE; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; WARFARIN; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

HUMAN; HYDROCEPHALUS; LUNG VASCULAR RESISTANCE; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; VASODILATATION; ARTICLE; FEMALE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION;

EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PURINES; SULFONES; THROMBOEMBOLISM; VASODILATOR AGENTS;

EID: 34548800378     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060391     Document Type: Review

References (20)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004; 351:1425-36.
2. McMillan E, Martin WL, Waugh J et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus. 2002; 11:392-8.
3. Bonnin M, Mercier FJ, Sitbon O et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005; 102:1133-7.
4. Bildirici I, Sumway JB. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery. Obstet Gynecol. 2004; 103:1102-5.
5. Weiss BM, Zemp L, Seifert B et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998; 31:1650-7.
6. Wong PS, Constantinides S, Kennedy CR et al. Primary pulmonary hypertension in pregnancy. J R Soc Med. 2001; 94: 523-6.
7. Bendayan D, Hod M, Oron G et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005; 106:1206-10.
8. Goodwin TM, Gherman RB, Hameed A et al. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol. 1999; 180(1, pt. 1):64-7.
9. Kiss H, Egarter C, Asseryanis E et al. Primary pulmonary hypertension in pregnancy: a case report. Am J Obstet Gynecol. 1995; 172:1052-4.
10. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 6th ed. New York: Lippincott Williams & Wilkins; 2002.
11. Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth. 2001; 87:295-8.
12. Badalian SS, Silverman RK, Aubry RH et al. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension: a case report. J Reprod Med. 2000; 45:149-52.
13. Geohas C, McLaughlin VV. Successful management of pregnancy in a patient with Eisenmenger syndrome with epoprostenol. Chest. 2003; 124:1170-3.
14. Stewart R, Tuazon D, Olson G et al. Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest. 2001; 119:973-5.
15. O'Hare R, McLoughlin C, Milligan K et al. Anaesthesia for Caesarian section in the presence of severe primary pulmonary hypertension. Br J Anaesth. 1998; 81:790-2.
16. Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol. 1999; 93:494-8.
17. Elliot CA, Stewart P, Webster VJ et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J. 2005; 26:168-73.
18. Ventavis (iloprost) package insert. South San Francisco, CA: CoTherix; 2006 Jan.
19. Lacassie HJ, Germain AM, Valdes G et al. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004; 103:1118-20.
20. Molelekwa V, Akhter P, Kenna P et al. Eisenmenger's syndrome in a 27 week pregnancy - management with bosentan and sildenafil. Ir Med J. 2005; 98:87-8. Letter.